NovoCure Limited Banner Image

NovoCure Limited

  • Ticker NVCR
    Exchange NASDAQ More
  • Industry Medical Laboratories & Research More
  • Sector Healthcare More
NovoCure Limited Logo Image
  • 201-500 Employees
  • Based in Portsmouth, New Hampshire
Novocure is an oncology company developing a profoundly different cancer treatment centered on a proprietary therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma.
5.0 / 5.0 (1)

NovoCure Limited reports have an aggregate usefulness score of 5.0 based on 1 reviews.

NovoCure Limited

Most Recent Responsibility Report

NovoCure Limited
MOST RECENT 2023 Corporate Responsibility Report

NovoCure Limited does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Archived Responsibility Reports

Our service enables potential investors to review the most recent and archived NovoCure Limited Sustainability Report, NovoCure Limited Corporate Social Responsibility Report, NovoCure Limited CSR Report, NovoCure Limited Corporate Responsibility, NovoCure Limited CR Report, NovoCure Limited Citizenship Report, NovoCure Limited ESG Report, and NovoCure Limited Environmental Report online.
NovoCure Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!